Lycia Therapeutics

About:

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

Website: https://lyciatx.com

Twitter/X: LyciaTx

Top Investors: Blue Owl, Eli Lilly, Alexandria Venture Investments, Franklin Templeton, Invus

Description:

Lycia Therapeutics is the operator of a biotechnology firm that aims to research and produce first-in-class therapies. The company's lysosomal targeting chimeras (LYTACs) platform is used to develop therapeutics that degrade extracellular and membrane-bound proteins that drive a variety of difficult-to-treat diseases, such as cancer and autoimmune conditions, allowing doctors to obtain drugs to cure patients.